Article Text
Statistics from Altmetric.com
M Underwood
Professor M Underwood, University of Warwick, Coventry, UK; M.Underwood@warwick.ac.uk
STUDY DESIGN
Design:
randomised controlled trial (Topical or Oral Ibuprofen [TOIB]).
Allocation:
concealed.*
Blinding:
blinded (data collectors).*
STUDY QUESTION
Setting:
26 general practices in the UK.
Patients:
282 patients ⩾50 years of age (mean age 63 y, 54% women) with knee pain (97% with osteoarthritis). Exclusion criteria included history of, or awaiting, knee replacement, and recent knee injury.
Intervention:
the patient’s general practitioner prescribed or recommended preferential use of over-the-counter topical ibuprofen, applied according to manufacturer’s instructions (eg, 0.5 g per knee up to 3 times/d, equivalent to 75 mg/d of ibuprofen using a 5% preparation) (n = 138), or oral ibuprofen, up to 1.2 g/day (n = 144). Increased dose, …
Footnotes
Source of funding: Health Technology Assessment Programme; Goldshield Pharmaceuticals supplied starter packs of topical ibuprofen.